| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0490 |
Injection, belimumab, 10 mg |
598 |
381 |
$1.20M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,353 |
9,026 |
$770K |
| 99215 |
Prolong outpt/office vis |
1,668 |
1,617 |
$183K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,422 |
1,380 |
$163K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,585 |
1,407 |
$142K |
| 99205 |
Prolong outpt/office vis |
211 |
203 |
$28K |
| J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
15 |
12 |
$22K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
229 |
223 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
817 |
767 |
$11K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
355 |
318 |
$2K |
| 96401 |
|
16 |
13 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
91 |
87 |
$148.53 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
13 |
13 |
$38.61 |